Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled versus intravenous tobramycin for cystic fibrosis pulmonary exacerbations
ACTRN12609000016235Phase 4Recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tobramycin in cystic fibrosis (CF) (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoints: Improvement in lung function, Time to next admission and 1 more. Started Oct 2008; status: recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12609000016235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000016235.